XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue        
Patient service revenue, net $ 1,394,356 $ 1,054,806 $ 4,379,282 $ 3,502,836
Medicare shared savings revenue 2,419,312 767,744 2,419,312 767,744
Consulting and event revenue 69,595 217,605 229,114 268,025
Product revenue 161,456 512,325
Total revenue 4,044,719 2,040,155 7,540,033 4,538,605
Operating Expenses and Costs        
Practice salaries and benefits 739,024 590,690 2,305,993 1,910,897
Other practice operating expenses 549,086 548,667 1,790,874 1,633,380
Medicare shared savings expenses 1,748,585 759,848 2,157,555 824,084
Cost of product revenue 145,432 474,026
Selling, general and administrative expenses 1,147,591 958,874 3,661,206 2,116,159
Depreciation and amortization 205,311 25,151 623,438 74,811
Total Operating Expenses and Costs 4,535,029 2,883,230 11,013,092 6,559,331
Loss from operations (490,310) (843,075) (3,473,059) (2,020,726)
Other Income (Expenses)        
Loss on sales of marketable securities (281,606) (281,606)
Gain (loss) on extinguishment of debt (450,999) (4,957,168) (1,347,371)
Change in fair value of debt (79,062) (19,246) (198,764)
Amortization of original issue and debt discounts on notes payable and convertible notes (65,816) (530,930)
Change in fair value of derivative financial instruments 12,802 739,485
Change in fair value of contingent acquisition consideration 126,411 45,996 (234,678) 687
Interest income (expense) (4,118) (72,535) (13,083) (193,134)
Total other income (expenses) 122,293 (891,220) (5,224,175) (1,811,633)
Net loss before provision for income taxes (368,017) (1,734,295) (8,697,234) (3,832,359)
Provision for income taxes
Net loss (368,017) (1,734,295) (8,697,234) (3,832,359)
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants (88,393) (63,862) (265,179) (63,862)
Net loss to common stockholders $ (456,410) $ (1,798,157) $ (8,962,413) $ (3,896,221)
Net loss per share to common stockholders, basic and diluted:        
Basic (in Dollars per share) $ 0 $ (0.01) $ (0.04) $ (0.03)
Fully diluted (in Dollars per share) $ 0 $ (0.01) $ (0.04) $ (0.03)
Weighted average number of common shares:        
Basic (in Shares) 232,203,244 147,366,619 224,658,709 129,234,540
Fully diluted (in Shares) 232,203,244 147,366,619 224,658,709 129,234,540